Anosmia Clinical Trial - NAC Trial for Anosmia

Status Completed

Clinical Trial Summary

The purpose of this research study is to evaluate the use of NAC in the treatment of anosmia (a loss of the sense of smell). This drug is already approved by the Food and Drug Administration (FDA) for oral or pulmonary (lung) inhaled use for other medical conditions. However, there is research evidence that the medication may promote nerve recovery (help nerves work better after they are damaged). Since anosmia involves nerve problems, we believe the nasal spray may help treat anosmia. The medication has been in use for many years for other conditions, without safety problems.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02481609
Study type	Interventional
Source	University of Miami
Contact
Status	Completed
Phase	Early Phase 1
Start date	July 2014
Completion date	December 1, 2017

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT04964414` - Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19	Phase 1/Phase 2
Completed	`NCT05812209` - Stellate Ganglion Block to Treat Long COVID 19 Case Series
Completed	`NCT05445921` - Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction	Phase 1/Phase 2
Withdrawn	`NCT02179554` - Does Cardiopulmonary Bypass Change Olfaction?
Completed	`NCT04957563` - Clinical Utility of Olfactory Rehabilitation: Treatment for Pacients With Neurosensorial Anosmia	N/A
Terminated	`NCT03680911` - NAC for Head Trauma-induced Anosmia	Phase 3
Completed	`NCT04657809` - Clinical Assessment of Insulin Fast Dissolving Film in Treatment of Post Infection Anosmia	Phase 2
Completed	`NCT04853836` - Olfactory Disfunction and Co-ultraPEALut	Phase 4
Recruiting	`NCT05040659` - Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2
Recruiting	`NCT05562050` - Characteristics of the Anosmic Olfactory Mucosa
Completed	`NCT05152030` - The Clinical Applicability of the 'TIB' Olfactory Test Device
Recruiting	`NCT05384561` - Olfactory Training as a Treatment for Olfactory Dysfunction Post COVID-19	N/A
Enrolling by invitation	`NCT04764981` - Olfactory Training for Olfactory Dysfunction After Coronavirus Disease - 19 (COVID-19)	N/A
Withdrawn	`NCT04408391` - Brain MRI Imaging in Patients With SARS-Cov2 (COVID-19) Infection With or Without Anosmia
Completed	`NCT04361474` - Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity	Phase 3
Completed	`NCT03990766` - Smell Changes & Efficacy of Nasal Theophylline	Phase 2
Completed	`NCT04797936` - BNO 1030 Extract (Imupret) in the Treatment of Mild Forms of COVID-19	Phase 4
Recruiting	`NCT04528329` - Anosmia and / or Ageusia and Early Corticosteroid Use	Phase 4
Completed	`NCT04789499` - Smell in Covid-19 and Efficacy of Nasal Theophylline	Phase 2
Recruiting	`NCT04384042` - Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control Study